The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
Disorders of Steroid 17α-Hydroxylase Deficiency
Abstract
The human P450c17 alpha gene (CYP17) is a single copy gene located in chromosome 10, consisting of 8 exons and 7 introns. 17 alpha-Hydroxylase/17,20-lyase deficiency is one of two hypertensive forms of congenital adrenal hyperplasia and is inherited as an autosomal recessive trait; although rare, it probably exists with twice the frequency of the 11 beta-hydroxylase deficiency. Deficient 17 alpha-hydroxylation of pregnenolone and progesterone and subsequent deficiency of the cleavage of the C-17,20 carbon bond result in the absence of sex hormone formation in both the adrenal glands and the gonads, causing hypogonadism and male pseudohermaphroditism. Elevated and glucocorticoid-suppressible levels of the ZF 17-deoxysteroids--DOC and corticosterone--as well as their 18-hydroxylated products--18-OHDOC and 18-OHB (in addition to 19-nor-DOC)--are responsible for hypertension, hypokalemia, and renin and aldosterone suppression. A few cases, reported primarily among Japanese families, have basal hyperaldosteronism, an enigmatic condition that still demands adequate explanation. Like other forms of congenital adrenal hyperplasia, treatment of 17 alpha-hydroxylase deficiency consists of replacement doses of glucocorticoid hormones and supplemental estrogen therapy in the young adult patient. Heterozygotes may be detected by slightly exaggerated responses of some or all the ZF 17-deoxysteroids to ACTH stimulation, and by the elevated ratio of total urinary metabolites of corticosterone to the total metabolites of cortisol.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with severe mutations in P450c17 cannot synthesize cortisol but instead increase corticosterone production (647) (as do rodent adrenals, which normally lack P450c17), explaining why they are not glucocorticoid-deficient, despite the lack of cortisol (Fig. 13).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [647]
Citations
Cites
Molecular biology of steroid hormone synthesis
MILLER, W. L. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-295 · Cited by 1,397
Williams' Textbook of Endocrinology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-816_5 · Cited by 1,156
Nebert, D. W., Nelson, D. R., Adesnik, M., Coon, M. J., Estabrook, R. W., Gonzalez, F. J., Guengerich, F. P., GUNSALUS, I. C., Johnson, E. F., KEMPER, B. W., et al. (1989) · DNA · doi:10.1089/dna.1.1989.8.1 · Cited by 606
17-Hydroxylation deficiency in man
Biglieri, E. G., Herron, M. A., & Brust, N. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105499 · Cited by 561
Self-citationChung, B. C., Picado-Leonard, J., Haniu, M., Bienkowski, M., Hall, P. F., Shively, J. E., & Miller, W. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.407 · Cited by 444
PICADO-LEONARD, J., & MILLER, W. L. (1987) · DNA · doi:10.1089/dna.1987.6.439 · Cited by 415
17α-Hydroxylase/17,20 lyase deficiency: from clinical investigation to molecular definition
YANASE, T., SIMPSON, E. R., & WATERMAN, M. R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-1-91 · Cited by 390
Expression of Bovine 17α-Hydroxylase Cytochrome P-450 cDNA in Nonsteroidogenic (COS 1) Cells
Zuber, M. X., Simpson, E. R., & Waterman, M. R. (1986) · Science · doi:10.1126/science.3535074 · Cited by 388
Wright, A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_5 · Cited by 377
Hypertension: Physiopathology and Treatment
Breslin, D. J. (1984) · JAMA · doi:10.1001/jama.1984.03340440083043 · Cited by 292
Congenital Adrenal Hyperplasia
White, P. C., New, M. I., & Dupont, B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162406 · Cited by 286
Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease.
Chrousos, G. P., Vingerhoeds, A. C. M., Brandon, D. D., Eil, C., Pugeat, M., Devroede, M., Loriaux, D. L., & LIPSETT, M. B. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110565 · Cited by 249
Nakajin, S., Shinoda, M., Haniu, M., Shively, J. E., & Hall, P. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43191-7 · Cited by 212
Multiple Factors Contribute to the Pathogenesis of Hypertension in Cushing's Syndrome
Saruta, T., Suzuki, H., Handa, M., IGARASHI, Y., Kondo, K., & Senba, S. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-2-275 · Cited by 206
PLASMA AND URINARY CORTICOSTEROIDS IN THE HYPERTENSIVE FORM OF CONGENITAL ADRENAL HYPERPLASIA
Eberlein, W. R., & Bongiovanni, A. M. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65119-1 · Cited by 169
Kagimoto, M., Winter, J. S. D., Kagimoto, K., Simpson, E. R., & Waterman, M. R. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-6-564 · Cited by 161
MATTESON, K. J., PICADO-LEONARD, J., CHUNG, B.-C., MOHANDAS, T. K., & MILLER, W. L. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-789 · Cited by 160
SPARKES, R. S., KLISAK, I., & MILLER, W. L. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.359 · Cited by 149
Peterson, R. E., Imperato-McGinley, J., Gautier, T., & Shackleton, C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131903 · Cited by 148
Congenital Adrenal Hyperplasia
White, P. C., New, M. I., & Dupont, B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706183162506 · Cited by 122
Sakaguchi, M., Mihara, K., & Sato, R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3361 · Cited by 117
Hemodynamic Characteristics of Primary Aldosteronism
Tarazi, R. C., Ibrahim, M. M., Bravo, E. L., & Dustan, H. P. (1973) · New England Journal of Medicine · doi:10.1056/nejm197312202892502 · Cited by 99
Dexamethasone-Suppressible Hyperaldosteronism
New, M. I., Siegal, E. J., & Peterson, R. E. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-1-93 · Cited by 84
Levine, L. S., Rauh, W., Gottesdiener, K. M., CHOW, D. M., Günczler, P., Rapaport, R., PANG, S., Schneider, B., & New, M. I. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-258 · Cited by 74
MELBY, J. C. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-4-697 · Cited by 66
Deoxycorticosterone Production and Regulation in Man*
Schambelan, M., & Biglieri, E. G. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-4-695 · Cited by 63
Kater, C. E., Biglieri, E. G., Brust, N., CHANG, B. C. F., HIRAI, J., & Irony, I. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-2-149 · Cited by 63
Volume-pressure relationships during development of mineralocorticoid hypertension in man.
Wenting, G. J., Veld, A. J. M. I. '., Verhoeven, R. P., Derkx, F. H. M., & Dh, S. (1977) · PubMed · Cited by 52
Kater, C. E., Biglieri, E. G., Brust, N., CHANG, B. C. F., & HIRAI, J. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-2-295 · Cited by 48
17α-Hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family
D'Armiento, M., Reda, G., Kater, C., Shackleton, C. H. L., & Biglieri, E. G. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-4-697 · Cited by 47
Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia
Holcombe, J. H., Keenan, B. S., Nichols, B. L., Kirkland, R. T., & Clayton, G. W. (1980) · Pediatrics · doi:10.1542/peds.65.4.777 · Cited by 44
Pathophysiology of Deoxycorticosterone-Secreting Adrenal Tumors*
Irony, I., Biglieri, E. G., Perloff, D. L., & Rubinoff, H. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-5-836 · Cited by 44
Diagnosis and Natural History of 17-Hydroxylase Deficiency in a Newborn Male*
Dean, H., Shackleton, C. H. L., & Winter, J. S. D. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-513 · Cited by 43
1 Pathogenesis of mineralocorticoid hypertension
Schalekamp, M. A. D. H., Wenting, G. J., & Veld, A. J. M. I. '. (1981) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(81)80005-9 · Cited by 40
Waldhäusl, W. K., Herkner, K. R., Nowotny, P., & Bratusch-Marrain, P. R. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-2-236 · Cited by 34
Yamakita, N., MURASE, H., Yasuda, K., Noritake, N., MERCADO-ASIS, L. B., & Miura, K. (1989) · Endocrinologia Japonica · doi:10.1507/endocrj1954.36.515 · Cited by 33
Kater, C. E., Biglieri, E. G., Rost, C. R., Schambelan, M., HIRAI, J., CHANG, B. C. F., & Brust, N. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-2-225 · Cited by 32
Plasma and Urinary 19-Nor-Deoxycorticosterone in 17α-Hydroxylase Deficiency Syndrome*
Griffing, G. T., WILSON, T. E., HOLBROOK, M. M., Dale, S. L., Jackson, T. K., Ullrich, I. H., & Melby, J. C. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-5-1011 · Cited by 32
Biglieri, E. G., & Kater, C. E. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30267-6 · Cited by 28
Characterization of Adrenocorticotropin Secretion in a Patient with 17α-Hydroxylase Deficiency*
Moreira, A. C., Leal, A. M. O., & de Castro, M. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-1-86 · Cited by 26
Kaplan, N. M. (1991) · The Endocrinologist · doi:10.1097/00019616-199106000-00010 · Cited by 26
Kater, C. E., & Biglieri, E. G. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91166-x · Cited by 23
Elevated Urinary 19-Nor-Deoxycorticosterone Glucuronide in Cushing’s Syndrome*
Ehlers, M. E., Griffing, G. T., WILSON, T. E., & Melby, J. C. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-926 · Cited by 22
An Autopsy Case of 17α-Hydroxylase Deficiency with Malignant Hypertension
Morimoto, I., Maeda, R., Izumi, M., Ishimaru, T., Nishimori, I., & Nagataki, S. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-5-915 · Cited by 22
Benign Desoxycorticosterone-Producing Adrenal Tumor
Kondo, K. (1976) · JAMA · doi:10.1001/jama.1976.03270100042026 · Cited by 21
No Linkage between HLA and Congenital Adrenal Hyperplasia Due to 17-Alpha-Hydroxylase Deficiency
Mantero, F., Scaroni, C. M., Pasini, C. V., & Fagiolo, U. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008283030923 · Cited by 21
Heterozygotes for 17α-hydroxylase deficiency can be detected with a short ACTH test
WIT, J. M., VAN ROERMUND, H. P. C., OOSTDIJK, W., BENRAAD, T. H. J., THIJSSEN, J. H. H., BOER, P., JANSEN, M., SPIT, M., & VAN DEN BRANDE, J. L. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03858.x · Cited by 18
Portales, J. A. R., Arteaga, E., Moreno, J. M. L., & Biglieri, E. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-349 · Cited by 17
Hypokalemic myopathy associated with 17α‐hydroxylase deficiency
Yazaki, K., Kuribayashi, T., Yamamura, Y., Kurihara, T., & Araki, S. (1982) · Neurology · doi:10.1212/wnl.32.1.94 · Cited by 11
Rohmer, V., Barbot, N., Bertrand, P., NAHOUL, K., Bigorgne, J., & Forest, M. G. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-523 · Cited by 10
No Linkage between HLA and Congenital Adrenal Hyperplasia Due to 17α-Hydroxylase Deficiency
D’Armiento, M., Reda, G., Bisignani, G., Tabolli, S., Cappellaci, S., Lulli, P., Carbonara, A. O., & Biglieri, E. G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198304213081621 · Cited by 8
Moreira, A. C., Leal, A. M. O., & de Castro, M. (1992) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003328 · Cited by 7
Hypokalemic Crisis Simulating Intestinal Obstruction in a 4-Year-Old Girl
PREEYASOMBAT, C. (1976) · American journal of diseases of children · doi:10.1001/archpedi.1976.02120110105016 · Cited by 5
Research works printed but not linked: 6
- Bravo, 1986, Calcium channel blockade with nifedipine in primary aldosteronism, Hypertension, 8, I191
- Fraser, 1987, Severe hypertension with absent secondary sex characteristics due to partial deficiency of steroid 17α-hydroxylase activity, J Hum Hypertens, 1, 53
- Kagawa, 1988, A new variant of congenital adrenal hyperplasia (CAH) with combined deficiencies of 17α-hydroxylase, 17,20-desmolase and 21-hydroxylase, Acta Pediatr Jpn, 30, 239
- Rovner, 1978, Direct evidence for a functional block in 18-oxidation in a patient with 17α-hydroxylase deficiency, Trans Assoc Am Physicians, 91, 416
- Shackleton, 1983, Evidence supporting the renal synthesis of 19-nor-DOC, Clin Exp Hypertens, A6, 939
- Waseda, 1986, A case of 17α-hydroxylase deficiency with normal blood pressure, Clin Endocrinol Tokyo, 34, 264
Cited by
Sorted by citations
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Molecular Genetics of Human Blood Pressure Variation
Lifton, R. P. (1996) · Science · doi:10.1126/science.272.5262.676 · Cited by 623
THE GENETICS, PATHOPHYSIOLOGX, AND MANAGEMENT OF HUMAN DEFICIENCIES OF P450c17
Auchus, R. J. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70021-5 · Cited by 266
Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic
Auchus, R. J. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.002 · Cited by 241
Kalantaridou, S., Davis, S. R., & Nelson, L. M. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70051-7 · Cited by 205
Metadata
- Authors
- Kater, C. E., & Biglieri, E. G.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Kater, Claudio E.
- ORCID
- Kater, Claudio E.
- Venue
- Endocrinology and Metabolism Clinics of North America
- Publisher
- Elsevier BV
- Published
- 1994-06
- Volume
- 23
- Issue
- 2
- Pages
- 341-357
- ISSN
- 0889-8529 (ISSN-L)
- OpenAlex
- W4296153575
- Cited by
- 146
- References
- 55
- Citations by year
- 2025: 6 · 2024: 6 · 2023: 8 · 2022: 7 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 4 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 4
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology and Metabolism Clinics of North America (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- 17-hydroxylase deficiency, 17,20-lyase deficiency, congenital adrenal hyperplasia, mineralocorticoid hypertension, hypokalemia, hyperaldosteronism, hypogonadism, pseudohermaphroditism, renin suppression, aldosterone suppression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review